Biotherapy

The Incidence and Clinical Significance of Antibodies to Interferon-a in Patients with Solid Tumors
pp. 1-5(5)
Authors: Öberg K.; Alm G.

Interferon antibodies in patients with infectious diseases.
pp. 7-14(8)
Authors: Antonelli G.; Simeoni E.; Currenti M.; De Pisa F.; Colizzi V.; Pistello M.; Dianzani F.

Treatment-induced antibodies to interleukin-2
pp. 15-24(10)
Authors: Prümmer O.

Natural antibodies to IL-2
pp. 25-28(4)
Authors: Balsari A.; Caruso A.

Natural antibodies to interferon-gamma
pp. 29-37(9)
Authors: Caruso A.; Turano A.

Anti-cytokine autoantibodies: Epiphenomenon or critical modulators of cytokine action
pp. 39-48(10)
Authors: van der Meide P.H.; Schellekens H.

Potential therapeutic use of antibodies directed towards HuIFN-
pp. 49-57(9)
Authors: Froyen G.; Billiau A.

Structure-activity of type I interferons
pp. 59-86(28)
Author: Viscomi G.C.

Measurement of cytokine antibodies. Test development
pp. 87-92(6)
Authors: Svenson M.; Herbrink P.

The Expression of Potency of Neutralizing Antibodies for Interferons and Other Cytokines
pp. 93-98(6)
Authors: Grossberg S.E.; Kawade Y.